insight wcg
wcg beat ep half upsid core earn
out-performance rest lower qualiti item tax invest incom
encourag pdp strong result assuag advers select
concern book grow year wcg longer provid guidanc
light cnc/wcg deal rais ep estim estim add
anoth accret acquisit wcg
larg ep upsid driven mix line item
ep beat consensu roughli upsid
lower tax higher invest incom would attribut balanc
higher-than-expect core oper name stronger result higher revenu
beat pdp lower estim addit
beat estim flat yoy medicaid littl
higher model manag character in-lin expect
wcg new valu script product reson market help drive yoy
enrol growth fast growth come concern advers select risk
compani signal intra-quart earli trend look posit today complet
view show remark strong result increas confid risk
profil new member consist better wcg expect
slower start membership growth margin higher expect
enrol grew qoq modestli compani expect
make harder achiev organ growth year-end believ
reason expect year howev mention
strong start earn track exceed wcg previou
expect look ahead wcg net rate inclus
strong wcg result posit read
increas ep project littl less
out-performance give credit tax upsid
compani reiter full-year tax rate ad higher wcg
net incom pro forma wcg model yield anoth accret
modestli increas year accret
pt multipl ep pt reflect
announc takeout consider cash stock current valu
risk margin pressur new contract rise cost trend integr regulatori
approv cnc/wcg
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
close wcg acquisit
grow organ revenu
meridian accret
uam meridian acquisit highli accret
creat diversifi profil
opportun cross-walk star legaci wcg
contract non-bonu uam bonu contract
result pharmaci rebid earli renew
close wcg
higher bid offer
renegoti attract pharmaci contract
pleas see import disclosur inform page report
financi summari market data
estim valuat
pleas see import disclosur inform page report
pleas see import disclosur inform page report
wellcar health earn summaryreport end decemb thousand except ep incom medicaid premium industri fee total oper product invest incom total medic product medicaid premium product sold- depreci oper interest equiti earn unconsolid pre-tax provis incom net non- dilut non-recur item net na na net incom incl non-recur dilut share common sizemed benefit bp product servic product servic total revenu net medicaid tax bpsdepreci amort bpsoper incom total bpsinterest bpspre-tax bpstax bpsnet medicar membershipmedicar prescript drug total medicar total segment performancemedicaid medicar revenuemedicar advantag prescript drug total medic benefit ratio bpsmedicar bpsreportedpercentag changediffer equiti research
pleas see import disclosur inform page report
wellcar health plan inc provid manag care servic target government-sponsor health care program focus
medicaid medicar headquart tampa florida wellcar offer varieti health plan famili children age
blind disabl well prescript drug plan
pt ep risk margin pressur new contract rise cost trend integr regulatori
approv cnc/wcg
pt ep risk implement new win integr exchang risk util
regul sustain
david windley cfa certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
david styblo cfa certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate
secur averag secur price consist expect total return price appreci plu yield plu minu
within period under-perform rate secur averag secur price consist expect
total return price appreci plu yield minu less within period
nr invest rate price target temporarili suspend suspens complianc applic
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic
secur regul prohibit certain type commun includ invest recommend
pleas see import disclosur inform page report
monitor describ secur whose compani fundament financi monitor financi project
opinion invest merit compani provid
jefferi methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ
restrict analys market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash
price-to-earnings sum part net asset valu dividend return return equiti roe next month
jefferi franchis pick includ stock select among best stock idea equiti analyst month period
stock select base fundament analysi may take account factor analyst convict differenti
analysi favor risk/reward ratio invest theme jefferi analyst recommend jefferi franchis pick
includ buy rate stock number vari depend analyst recommend inclus stock ad
new opportun aris remov reason inclus chang stock met desir return longer rate
buy and/or trigger stop loss stock day volatil bottom quartil stock continu
stop loss remaind stop franchis pick intend repres recommend portfolio stock
sector base may note believ pick fall within invest style growth valu
risk may imped achiev price target
report prepar gener circul provid invest recommend specif individu investor
financi instrument discuss report may suitabl investor investor must make
invest decis base upon specif invest object financi situat util financi advisor
deem necessari past perform financi instrument recommend report taken indic
guarante futur result price valu incom financi instrument mention report rise well
fall may affect chang econom financi polit factor financi instrument denomin currenc
investor home currenc chang exchang rate may advers affect price valu incom deriv
financi instrument describ report addit investor secur adr whose valu affect
currenc underli secur effect assum currenc risk
compani mention report
rate price target histori wellcar health plan inc wcg
pleas see import disclosur inform page report
